| Literature DB >> 21708510 |
Helen H Suh1, Antonella Zanobetti, Joel Schwartz, Brent A Coull.
Abstract
BACKGROUND: Health risks differ by fine particle (aerodynamic diameter ≤ 2.5 μm) component, although with substantial variability. Traditional methods to assess component-specific risks are limited, suggesting the need for alternative methods.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21708510 PMCID: PMC3230427 DOI: 10.1289/ehp.1002646
Source DB: PubMed Journal: Environ Health Perspect ISSN: 0091-6765 Impact factor: 9.031
Pollutants by category.
| Pollutant category | Pollutants |
|---|---|
| Inert (nonaromatic, nonalkane) | Cyclopentane, methylcyclopentane, methylcyclohexane, sulfur, EC, CO, NO2 |
| Polar (nonaldehyde) | Acetic acid, 2-butanone, organic carbon |
| Aromatic | Benzene, toluene, ethylbenzene, |
| Aldehyde | Benzaldehyde, heptanal, hexanal, octanal |
| Alkane | 2,2,4-Trimethylpentane, 2,2-dimethylbutane, 2,3,4-trimethylpentane,
2,3-dimethylbutane, propane, 2,3-dimethylpentane, 2,4-dimethylpentane,
2-methylheptane, 2-methylhexane, 2-methylpentane, 3-ethylhexane,
3-methylhexane, 3-methylpentane, ethane, isobutane, isopentane,
|
| Acidic | Acetic acid, nitric acid, sulfur, sulfur dioxide |
| Combustible | Ethane, propane, isobutane, |
| Transition metal oxide | Copper, manganese, zinc, titanium, iron oxide |
| Microcrystalline oxide | Arsenic, bromine, selenium, lead, silicon oxide |
Daily cause-specific hospital admissions, 1998–2006.
| Percent distribution of daily admissions | Maximum daily admissions | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cause | 5 | 25 | 50 | 75 | 95 | |||||||
| CVD | 54 | 69 | 79 | 91 | 107 | 132 | ||||||
| MI | 1 | 2 | 3 | 5 | 7 | 12 | ||||||
| CHF | 13 | 18 | 21 | 26 | 33 | 47 | ||||||
| IHD | 13 | 18 | 22 | 26 | 32 | 40 | ||||||
| Atrial fibrillation | 11 | 16 | 19 | 23 | 30 | 39 | ||||||
| Respiratory | 25 | 32 | 38 | 44 | 56 | 76 | ||||||
| COPD | 11 | 16 | 20 | 24 | 32 | 43 | ||||||
| ARI | 0 | 0 | 1 | 2 | 3 | 10 | ||||||
| Pneumonia | 2 | 5 | 6 | 9 | 14 | 28 | ||||||
| Causes were defined using ICD-9-CM codes. Data are for all years. Sample size is 729 days, with 271 in winter (November–March) and 458 in summer (April–October). | ||||||||||||
Figure 1Percent change in CVD hospital admissions per IQR change in pollutant property by exposure window for all data (A) and by season (B) for 24-hr moving averages: two-pollutant property groupings (groups A and B). “Inert” does not include aromatics or alkanes; “polar” does not include aldehydes. Exposure windows include day of admission and 2-day, 3-day, and 4-day moving averages (MA) including day of admission. Abbreviations: Sum, summer season; Win, winter season.
Figure 2Percent change in CVD (A) and respiratory (B) hospital admissions per IQR change in each pollutant: results from first stage grouped by pollutant property (24-hr moving averages). “Inert” does not include aromatics and alkanes; “polar” does not include aldehydes. Solid circles indicate the 5th and 95th percentiles, whiskers the 10th and 90th percentiles, and boxes the 25th and 75th percentiles. The dotted (gray) line represents the median, while the solid line represents the mean. The red bars indicate percent change in CVD or respiratory hospital admissions for each pollutant property for 2-stage Group A and Group B models.
Figure 3Percent change in respiratory hospital admissions per IQR change in pollutant property by exposure window for all data (A) and by season (B) for 24-hr moving averages: two-pollutant property groupings (groups A and B). “Inert” does not include aromatics and alkanes; “polar” does not include aldehydes. Exposure windows include day of admission and 2-day, 3-day, and 4-day moving averages (MA) including day of admission. Abbreviations: Sum, summer season; Win, winter season.
Figure 4Relation of hospital admissions for CHF (A), IHD (B), atrial fibrillation (C), and MI (D) and 24-hr averaged pollutant properties, all year and by season: two-pollutant property groupings (groups A and B). “Inert” does not include aromatics and alkanes; “polar” does not include aldehydes. Abbreviations: Sum, summer season; Win, winter season.
CVD hospital admission results by different first-stage models: 24-hr exposures on the day of admission [percent change (95% CI)].
| Pollutant category | Multipollutant + ozone | Single pollutant + ozone | ||
|---|---|---|---|---|
| Inert | –0.203 (–0.701 to 0.222) | –0.270 (–0.703 to 0.046) | ||
| Polar | –0.316 (–1.075 to 0.484) | –0.332 (–1.141 to 0.568) | ||
| Aromatic | –0.256 (–0.520 to 0.001) | –0.141 (–0.324 to 0.069) | ||
| Aldehyde | 0.064 (–0.307 to 0.438) | –0.314 (–1.135 to 0.316) | ||
| Acidic | 0.381 (–0.299 to 1.065) | 0.056 (–0.969 to 0.952) | ||
| Combustible | 0.065 (–0.017 to 0.157) | –0.402 (–0.950 to 0.140) | ||
| Transition metal oxide | 0.259 (0.023 to 0.479) | 0.158 (–0.676 to 0.743) | ||
| Microcrystalline oxide | –0.401 (–0.737 to –0.032) | –0.534 (–1.126 to –0.078) |
Figure 5Relation of hospital admissions for COPD (A), ARI (B), and pneumonia (C) and 3-day averaged pollutant properties, all year and by season: two-pollutant property groupings (groups A and B). “Inert” does not include aromatics and alkanes; “polar” does not include aldehydes. Abbreviations: Sum, summer season; Win, winter season.